Faculity of Medicine, Zagazig University
Zagazig, Egypt
Location status: Recruiting
NCT Number: NCT07235982
Improving pain in the patients with adhesive capsulitis by comparing the effect of combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection.
Interested in participating?
Request Info41 year–65 year
All sexes
Interventional
Not applicable
Zagazig, Egypt
Location status: Recruiting
Comparing between combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection for enhancing pain relief in adhesive capsulitis as regards:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will receive ultrasound guided (SHAC) block combined with intraarticular steroid injection of the affected shoulder joint followed by home exercise program.
patients will receive intraarticular steroid injection of the affected shoulder joint followed by home exercise program
Time frame: BEFORE STARTING PROCEDURE (0 hour)(baseline)
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: 15 minutes after the procedure
measured by Visual Analogue Scale(VAS) as 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: first 6 hours postoperative
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: one week after procedure
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: 3 weeks after procedure
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: 6 weeks after procedure
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: 8 weeks after procedure
measured by Visual Analogue Scale (VAS) 10 cm line labelled (0-10), in which 0 presents no pain and 10 represents the worst pain in each participant
Time frame: baseline (0 ) and subsequently at one week, 3 weeks , 6 weeks and 8 weeks after procedure
SPADI contains 13 items that assess two domains - a five item subscale that measures pain and an eight item subscale that measures disability. Each subscale scored 10 ranging from 0 (best) to 10 (worst). It is a self administered, valid questionnaire,
Time frame: first 24 hours
Total amount of rescue analgesia (ibuprofen)
Time frame: 1 week after procedure
degree of satisfaction of the analgesia by using a 5-points likert-like verbal scale (1 = very dissatisfied analgesia, 2 = dissatisfied analgesia, and 3 = neutral, 4=satisfied analgesia, and 5=very satisfied analgesia)
Time frame: 24 hours
Complications of SHAC block (local anesthetic toxicity, infection, bleeding)
Time frame: at baseline, first week and third week follow up post intervention.
Passive and active shoulder flexion, abduction, and external rotation will be measured using goniometer
Contact information is provided by the study sponsor or research team.
Zagazig University
Other Gov
Comparative Study Between Shoulder Anterior Capsular Block Plus Steroid Injection Versus Steroid Injection Alone for Pain Management in Adhesive Capsulitis: A Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05961800
Agnosia, Analgesia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05543694
Agnosia, Analgesia
Boston, Massachusetts, United States
View Trial DetailsNCT05555485
Agnosia, Analgesia
Galveston, Texas, United States
View Trial DetailsNCT06275698
Agnosia, Analgesia
Stevenage, United Kingdom
View Trial Details